API
Sitagliptin Phosphate
KDMF APIs
Sitagliptin Phosphate
Korean name | 시타글립틴인산염 |
|---|---|
Category | Other metabolic drugs |
CAS No. | 654671-78-0 |
KDMF registration No. | 수5217-4-ND |
Manufacturer | Mylan Laboratories Limited(Unit-1) |
Specification | In-house |
Product information
IUPAC Name | (3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one |
|---|---|
Synonyms | Sitagliptin |
Description | Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar. Sitagliptin was granted FDA approval on October 16, 2006. |
Certificate of Analysis | If you need more information, please contact us. |
If you need additional documents such as specifications or certificates of analysis, please request them together with your inquiry. Our team will review and reply. (02-579-1056 · ace@acebiopharm.com)